Literature DB >> 29600725

Overview of Impella and mechanical devices in cardiogenic shock.

Hymie Habib Chera1, Menachem Nagar1, Nai-Lun Chang1, Carlos Morales-Mangual1, George Dous1, Jonathan D Marmur1, Muhammad Ihsan1, Paul Madaj, Yitzhak Rosen.   

Abstract

INTRODUCTION: Cardiogenic shock (CS) is a life-threatening condition associated with significant morbidity and mortality. The Impella (Abiomed Inc.) is an axial flow pump on a pigtail catheter that is placed across the aortic valve to unload the left ventricle by delivering non-pulsatile blood flow to the ascending aorta. It is used for high-risk percutaneous coronary intervention and CS. AREAS COVERED: Percutaneous mechanical support devices are placed in a minimally invasive manner and provide life-saving assistance. We review Impella and other percutaneous devices such as intra-aortic balloon pump, TandemHeart, and extracorporeal membrane oxygenation (ECMO) and the evidence supporting their use in the setting of CS. EXPERT COMMENTARY: Impella has been proven to be safe and may be superior to other mechanical support devices in CS.

Entities:  

Keywords:  Cardiogenic shock; Impella; Mechanical support devices; intra-aortic balloon pump; mechanical circulatory support; percutaneous ventricular assist device

Mesh:

Year:  2018        PMID: 29600725     DOI: 10.1080/17434440.2018.1456334

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  7 in total

1.  Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data.

Authors:  Bernhard Wernly; Clemens Seelmaier; David Leistner; Barbara E Stähli; Ingrid Pretsch; Michael Lichtenauer; Christian Jung; Uta C Hoppe; Ulf Landmesser; Holger Thiele; Alexander Lauten
Journal:  Clin Res Cardiol       Date:  2019-03-21       Impact factor: 5.460

Review 2.  Mechanical Circulatory Support for Acute Heart Failure Complicated by Cardiogenic Shock.

Authors:  Min Suk Choi; Hunbo Shim; Yang Hyun Cho
Journal:  Int J Heart Fail       Date:  2020-01-22

3.  Left ventricle unloading strategies in ECMO: A single-center experience.

Authors:  Laura M Piechura; Antonio Coppolino; Gita N Mody; Daniel E Rinewalt; Mohammed Keshk; Mitsugu Ogawa; Raghu Seethala; Erin A Bohula; David A Morrow; Steve K Singh; Hari R Mallidi; Steven P Keller
Journal:  J Card Surg       Date:  2020-06-02       Impact factor: 1.620

4.  Percutaneous left ventricular advanced support for 'protected' complex high-risk transcatheter mitral valve repair: a case series.

Authors:  Iacopo Muraca; Matteo Pennesi; Nazario Carrabba; Fernando Scudiero; Angela Migliorini; Niccolò Marchionni; Pierluigi Stefàno; Renato Valenti
Journal:  Eur Heart J Case Rep       Date:  2020-04-03

5.  Impella use in real-world cardiogenic shock patients: Sobering outcomes.

Authors:  Khaled Q A Abdullah; Jana V Roedler; Juergen Vom Dahl; Istvan Szendey; Hendrik Haake; Lars Eckardt; Albert Topf; Bernhard Ohnewein; Peter Jirak; Lukas J Motloch; Bernhard Wernly; Robert Larbig
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

6.  Usefulness of Impella support in different clinical settings in cardiogenic shock.

Authors:  María Isabel Barrionuevo-Sánchez; Albert Ariza-Solé; Daniel Ortiz-Berbel; José González-Costello; Joan Antoni Gómez-Hospital; Victòria Lorente; Oriol Alegre; Isaac Llaó; José Carlos Sánchez-Salado; Josep Gómez-Lara; Arnau Blasco-Lucas; Josep Comin-Colet
Journal:  J Geriatr Cardiol       Date:  2022-02-28       Impact factor: 3.327

7.  Support with Impella versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: A protocol for systematic review and meta-analysis.

Authors:  Lingzhang Rao; Xianli Huang; Jinlan Luo
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.